We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BVXVW market cap is 0. The company's latest EPS is USD and P/E is N/A.
Quarter End | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Dec 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 11.2M | 0 | 0 | 9k |
Operating Income | -10.78M | 3.87M | -3.19M | -2.6M | -1.82M |
Net Income | -12.85M | 3.75M | -3.52M | -3.76M | -2.33M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 12.68M | 40k | 0 | 9k |
Operating Income | -78.35M | -55.47M | -34.83M | -11.06M | -9.71M |
Net Income | -109.19M | -4.46M | -39.98M | -5.8M | -6.5M |
Quarter End | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Dec 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
Total Assets | 85.57M | 74.72M | 23.29M | 19.9M | 17.47M |
Total Liabilities | 81.1M | 65.36M | 28.1M | 27.01M | 22.04M |
Total Equity | 4.47M | 9.36M | -4.81M | -7.11M | -4.57M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
Total Assets | 115.75M | 56.91M | 99.6M | 27.07M | 17.47M |
Total Liabilities | 180.8M | 71.51M | 76.27M | 28.83M | 22.04M |
Total Equity | -65.05M | -14.6M | 23.33M | -1.76M | -4.57M |
Quarter End | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Dec 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
Operating | N/A | N/A | -3.06M | N/A | -9.38M |
Investing | N/A | N/A | -6k | N/A | -637k |
Financing | N/A | N/A | N/A | N/A | 1.09M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
Operating | -77.06M | -72.54M | -24.48M | -7.27M | -9.38M |
Investing | -7.2M | -5.94M | -361k | -836k | -637k |
Financing | 85.21M | 13.72M | 67.78M | 6.78M | 1.09M |
Market Cap | 0 |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 0 |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 6 (70.59%) |
Company Name | BiondVax Pharmaceuticals Ltd |
Address |
jerusalem biopark, 2nd floor, hadassah ein kerem campus jerusalem, jerusalem 7403618 |
Website | https://www.biondvax.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions